Pure Global AI
Registration holder profile

DIASORIN LTDA

Brazil228 ANVISA registrations105 unique technical categoriesDec 27, 2001 – Feb 02, 2026
Verified
228
Total products
105
Technical names
Dec 2001
Earliest registration
Feb 2026
Latest registration
Regulatory footprint
Search DIASORIN LTDA across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this holder
MYCOBACTERIUM
Família LIAISON® Quantiferon TB Gold Plus II
Class III · Feb 02, 2026
ANTI-TSH RECEPTOR ANTIBODY (TRAb) - NEONATAL SCREENING
Família LIAISON® TSH-R Ab
Class III · Dec 15, 2025
FERRITIN - TUMOR MARKER
Familia LIAISON® Ferritina
Class III · Aug 04, 2025
PROSTATE-SPECIFIC ANTIGEN (PSA)
Família LIAISON® PSA II Gen
Class III · May 05, 2025
STREPTOCOCCUS
LIAISON® S. pneumoniae Ag
Class III · Mar 31, 2025
Most popular products
Products with most registrations
TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
21 registrations
Instrument intended for immunoassays
7 registrations
HERPES VIRUS (HHV 2)
6 registrations
HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV)
6 registrations
ANTINUCLEAR ANTIBODY (ANA)
5 registrations
Top manufacturers
Manufacturers with the most products registered by this holder
DIASORIN ITALIA S.P.A.
135 products
DIASORIN INC.
40 products
DIASORIN INC
19 products
DIASORIN MOLECULAR LLC
7 products
DIASORIN ITALIA S.P.A. UK BRANCH
6 products
Products per risk level
Distribution of distinct commercial products by ANVISA risk classification
Class I28Distinct Products · 28 total registrations
Class II92Distinct Products · 93 total registrations
Class III70Distinct Products · 70 total registrations
Class IV37Distinct Products · 37 total registrations
About this profile

Access comprehensive registration holder profile for DIASORIN LTDA through Pure Global AI's free Brazil medical device database. This registration holder manages 228 medical device registrations with ANVISA across 105 unique technical categories. Their regulatory portfolio spans from Dec 27, 2001 to Feb 02, 2026.

This page provides comprehensive insights including 5 recent product registrations with the latest being MYCOBACTERIUM (Família LIAISON® Quantiferon TB Gold Plus II), 5 most popular products led by TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL with 21 registrations, partnerships with 5 key manufacturers including DIASORIN ITALIA S.P.A. and DIASORIN INC., and products across 4 risk classifications with 28 Class I devices. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping distributors understand market dynamics and identify business opportunities.